One acquisition solution for integrated services plus (OASIS+) unrestricted multiple agency contract (MAC)
Active Awarded Last action
- Contract number
- 47QRCA25DU259
- Awardee
-
PPD Development LP UEI ZANENSW6C665
- Awarding agency
-
Federal Acquisition Service
General Services Administration
- Task orders
- 0
Award facts
- Opportunity
-
- GSA’s OASIS+ MAC Draft Request for Proposal #2 Pre-Solicitation · 47QRCA23R0006 · Posted Mar 2, 2021
- Last date to order 37% complete
- IDV ceiling
- $999,999,999,999.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 766 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The General Services Administration awarded an indefinite-delivery contract to PPD Development LP under the OASIS+ Unrestricted multiple-award program on December 17, 2024, with a contract ceiling of $999,999,999,999 and an ultimate completion date of December 16, 2029. This is a multiple-award vehicle with no set-aside category.
The OASIS+ Unrestricted IDIQ enables task-order work across federal agencies government-wide. PPD Development LP is a subsidiary of Thermo Fisher Scientific and operates as a clinical trial management and regulatory affairs services provider. The company's service offerings include clinical trial management, regulatory affairs support, data management, biospecimen tracking, and laboratory services delivered to federal agencies. PPD self-performs the substantial majority of its work.
The originating solicitation was posted on March 2, 2021, with a due date of March 29, 2023. The contract's period of performance runs through December 16, 2029.
As a large business entity competing without set-aside designations, PPD's federal customer base concentrates in health-focused agencies. Recent substantial task-order activity under related PPD vehicles reflects ongoing demand: a $186.4 million NIAID Clinical Site Monitoring order (February 2024), a $75.2 million HIV and infectious diseases clinical research support order (August 2024), and a $222.1 million ASPR Phase 2 ARDS clinical trial contract (December 2023). This OASIS+ Unrestricted vehicle positions PPD to compete for additional task orders across civilian federal agencies requiring clinical research, regulatory, and integrated services capabilities.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,500 |
Quick answers
Who was awarded contract 47QRCA25DU259?
47QRCA25DU259 was awarded to PPD Development LP by Federal Acquisition Service (General Services Administration) on December 17, 2024.
How much is contract 47QRCA25DU259 worth?
47QRCA25DU259's own ceiling is $999,999,999,999.
Who can order from contract 47QRCA25DU259?
47QRCA25DU259 is a multiple award indefinite delivery contract. All agencies can place orders on it.
Is contract 47QRCA25DU259 part of a contract vehicle?
Yes. 47QRCA25DU259 is part of One Acquisition Solution for Integrated Services Plus - Unrestricted (OASIS+ Unrestricted).
Was contract 47QRCA25DU259 competed?
The extent of competition for 47QRCA25DU259 was full and open competition. The government received 766 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV